- Lobbying
- Lobbying by GENERIC ANIMAL DRUG ALLIANCE
Lobbying Relationship
Bills mentioned
H.R.8857: Generic Animal Drug Advancement Act
Sponsor: Nancy Mace (R-S.C.)
H.R.1683: Generic Animal Drug Advancement Act
Sponsor: Nancy Mace (R-S.C.)
H.R.1418: Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Sponsor: Greg Pence (R-Ind.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Theodore Sullivan | n/a |
Jon Plebani | n/a |
Edward Allera | n/a |
Karen Lynch-Calton | n/a |
Michael Strazzella | n/a |
Timothy Costa | n/a |
Elizabeth Westbrook | n/a |
Alice Nettles | n/a |
Sophia Estupinan | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
Food & Drug Administration (FDA)
Health Issues
Medical
Pharmacy
U.S. House of Representatives
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
U.S. Senate
Food & Drug Administration (FDA)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate